IMMUNOCORE HLDGS ADS/1 Net Asset Quality Index

Latest as of June 2026: 37.5%

IMMUNOCORE HLDGS ADS/1 net asset quality index. IMMUNOCORE HLDGS ADS/1 (6YG) has a Net Asset Quality Index of 37.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €1.12 Billion minus total liabilities of €699.62 Million yields net assets of €419.80 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is IMMUNOCORE HLDGS ADS/1's book value for net asset value and shareholders' equity analysis.

Quality Index

37.5%
Equity / Total Assets

Net Assets

€419.80 Million
EUR

Total Assets

€1.12 Billion
EUR

Total Liabilities

€699.62 Million
EUR

Net Asset Quality Index of IMMUNOCORE HLDGS ADS/1 (2022–2025)

Net asset quality index of IMMUNOCORE HLDGS ADS/1 from 2022 to 2025. This chart shows how IMMUNOCORE HLDGS ADS/1's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the index stands at 37.5%, representing net assets of €419.80 Million against total assets of €1.12 Billion EUR. Check 6YG strategic asset allocation to assess the company's strategic physical and investment asset allocation.

IMMUNOCORE HLDGS ADS/1 Net Asset Quality Index by Year (2022–2025)

IMMUNOCORE HLDGS ADS/1 net asset quality index by year from 2022 to 2025. The table below presents the year-by-year Net Asset Quality Index for IMMUNOCORE HLDGS ADS/1 from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see IMMUNOCORE HLDGS ADS/1 stock valuation.

Year Quality Index Net Assets (EUR) Total Assets Total Liabilities Change (pp)
2025 35.7% €381.03 Million €1.07 Billion €686.24 Million ▼ 0.0 pp
2024 35.7% €360.72 Million €1.01 Billion €648.79 Million ▼ -26.1 pp
2023 61.8% €368.84 Million €597.00 Million €228.16 Million ▼ -2.6 pp
2022 64.3% €338.90 Million €526.76 Million €187.86 Million —
pp = percentage points